Redpoint Bio Corporation (OTC BB: RPBC), a leading biotechnology company, is focused on developing better tasting products for the pharmaceutical, food and beverage industries. The recent progression in taste biology has produced a number of new approaches to the discovery and development of innovative taste blockers and enhancers. The company leverages its modern tools of biotechnology to discover revolutionary ways to make medicines more palatable and enhance the taste of prepared foods and beverages. For further information, visit the Company’s web site at www.redpointbio.com.
- 18 years ago
QualityStocks
Redpoint Bio Corporation (OTC BB: RPBC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…